US › Healthcare

Milestone Scientific (MLSS)

US · Healthcare · Medical Instruments & Supplies

$0.46+4.80%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$2.2M

Revenue YoY

-3.2%

Net profit

$-839,853

Profit YoY

+57.9%

EPS

$-0.01

EPS estimate

$-0.01

Net margin

-38.8%

EPS came in at -0.01 against a street estimate of -0.01 — a beat of 0.0%.

Key statistics

Market cap

$35.3M

Forward P/E

18.2

P/B

15.45

Book value

$0.03

EPS (TTM)

$-0.06

52-week high

$0.68

52-week low

$0.22

50-day MA

$0.38

200-day MA

$0.33

Beta

1.04

Analyst view

Analysts rate Milestone Scientific a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $1.00.

Shareholding

Insiders

16.06%

Institutions

5.06%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Milestone Scientific — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.